๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Highlights from other journals - July 1999


Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
38 KB
Volume
1
Category
Article
ISSN
1464-3383

No coin nor oath required. For personal study only.

โœฆ Synopsis


Obesity is an increasingly common disease in the western world and incidence has been associated with a range of other diseases including hypertension, atherosclerosis and type II (non-insulin dependent) diabetes. However, little is known about the proteins that mediate gene control of lipid metabolism. One possible clue is the class of peroxisome proliferator activated receptors (PPARs), a family of nuclear receptors that respond to long-chain fatty acids and prostaglandins and that have been a subject of this column in previous months. Further study of this family of receptors might yield vital clues in the understanding of the signalling pathways that regulate energy balance.


๐Ÿ“œ SIMILAR VOLUMES


Highlights from other journals - March 1
๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 37 KB

The sarcodictyins A (1, R = Me) and B (1, R = Et), originally isolated from a soft coral, are complex natural products with potent antitumour activity through a taxol-like mode of action (tubulin polymerisation and microtubule stabilisation). In a recent paper, a solid-phase synthetic route to the s

Highlights from other journals - April 1
๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 39 KB

## Bicyclic Guanidine Libraries A novel method for the solid-phase synthesis of bicyclic guanidines has been described in a recent publication (J.M. Ostresh et al., J. Org. Chem., 63, (1998), 8622-8623). Following the preparation of acylated dipeptides (1) on methylbenzhydrylamine-derivatised poly

Highlights from other journals - May 199
๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 39 KB

Whilst ยต-opioid antagonists have been used for many years in the treatment of drug abuse, ฮบ antagonists might provide a more effective and longer-lasting treatment and novel agents provide an attractive target for drug discovery. The library described in this publication was based on 3,4-dimethyl-4-